Latest Juvenile Diabetes Research Foundation Stories
BURGESS HILL, England, September 1 /PRNewswire-FirstCall/ -- With some 20,000 UK children with Type 1 diabetes(i) about to start the new school year, new guidance from the National Institute for Health and Clinical Excellence (NICE) looks set to revolutionise the way children manage their diabetes, granting more freedom and control for their condition, by greater access to insulin pump therapy.
Scientists at the Stanford University School of Medicine are shedding light on how type-1 diabetes begins. Doctors have known the disease is caused by an autoimmune attack on the pancreas, but the exact trigger of the attack has been unclear.
By Stories by MADONNA YANCEY, Courier & Press correspondent Childhood should be a time filled with fun and promise. Not a time of worry and constant medical concerns. For Dana Lobel the wonder of childhood dimmed when her 10-year- old son, Ben, was diagnosed with type 1 diabetes.
EpiVax, Inc, a leader in the field of computational immunology, announced today that it has received a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a division of the National Institutes of Health (NIH), to develop "Epi-13", a novel therapeutic for the prevention and treatment of Type 1 diabetes, a devastating and chronic autoimmune disease that affects three million Americans.
INDIANAPOLIS, June 27 /PRNewswire-FirstCall/ -- Media conference call with Gary Hall Jr.: Monday, June 30, 2:00 PM EDT United States: (800) 553-0327 International: +1 (612) 332-0226 When Olympian Gary Hall Jr.
Osiris Therapeutics has received $2 million in milestone payments from the Juvenile Diabetes Research Foundation for progress made on a Phase II clinical trial evaluating Prochymal, a mesenchymal stem cell therapy, for patients recently diagnosed with type 1 diabetes.
Osiris Therapeutics, Inc.
One day it may be possible to mimic the tactics used by parasites to trick the body into accepting transplanted tissues or organs.
Scientists have discovered a new technique for turning embryonic stem cells into insulin-producing pancreatic tissue in what could prove a significant breakthrough in the quest to find new treatments for diabetes.
Researchers in Belgium have significantly advanced the discovery of a pancreatic progenitor cell with the capacity to generate new insulin-producing beta cells.